Our team has completed preclinical procedures across the most demanding fields in medical device development — from cardiovascular-to-neurovascular, BCI-to-surgical robotics. OECD GLP-certified since 2018, our 200+ employees across North America, Europe, and Asia keep medical devices safe, effective, and globally compliant.
Large-Animal Study for Innovative Medical Devices
Hover any service to explore what we deliver at each stage.
Large-Animal Study for Innovative Medical Devices
Based on your conversation, we've opened the service most relevant to you.
{{ card.title }}
{{ card.desc }}
{{ card.title }}
From First Concept to Global Submission
One partner across the whole journey. Your current stage is highlighted below.
{{ st.t }}
{{ st.d }}
10,000+ Procedures. 90%+ Success Rate.
The fields where our surgical teams work every day — yours is highlighted.
{{ f.t }}
Meet GoldenWing Around the World
Medtec Japan 2025 — Tokyo Medical Expo
Meet our team at the booth — cutting-edge preclinical technology on show.
PCR Tokyo Valves 2025
A premier global forum for cardiac valve innovation.
Research visit to RCSI — Royal College of Surgeons in Ireland
OECD Good Laboratory Practice certification obtained
Remarkable results at MEDICA 2024
Founded by Surgeons. Built for Innovators.
As a core member of Medphoenix Medical Group, GoldenWing Medical was founded in 2018 by renowned Chinese doctors with a mission to become a global leading one-stop service provider for innovative medical devices — medical research, preclinical large-animal testing, clinical trials and global registration. Our 18,000 m² laboratories are equipped with high-end medical equipment from Philips, Siemens and more.
Let's map your path to market
Tell us where your device is today and a GoldenWing specialist will follow up with guidance matched to your stage — from early R&D through GLP and global submission.
Thank you — we're on it
A GoldenWing specialist will follow up shortly with information matched to your stage.